Johnson & Johnson has produced the most convincing data to date that its combination of Rybrevant and Lazcluze could replace ...

The first-line combination of amivantamab-vmjw plus lazertinib extended OS compared with osimertinib for patients with EGFR-mutated advanced non-small cell lung cancer, according to data from the ...

Coeliac disease is an autoimmune condition where eating gluten triggers the immune system to attack the lining of the small ...

Thanks to the introduction of a vaccine in 1963, measles was considered eliminated in the US in 2000. Yet the highly contagious disease has reemerged as a threat in 2025 as declining vaccination rates ...

Dengue fever cases jump 15% in the Americas with Puerto Rico seeing a 113% increase. Learn vital prevention steps before ...

Designing the nursery is an exciting step for expectant parents. It gives you the chance to visualize the tiny new perso ...

Exelixis, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved CABOMETYX® (cabozantinib) for the treatment of 1) adult and pediatric patients 12 years of age and older ...